Orchestra BioMed Holdings (OBIO) Long-Term Investments (2020 - 2025)

Orchestra BioMed Holdings (OBIO) has reported Long-Term Investments for 6 consecutive years, with $2.5 million the latest figure, recorded in Q4 2025.

• In Q4 2025, Long-Term Investments changed 0.2% year-over-year to $2.5 million; the TTM figure through Dec 2025 stood at $2.5 million (changed 0.2% YoY), while the FY2025 annual figure was $2.5 million, changed 0.2% from the prior year.
• Long-Term Investments was little changed at $2.5 million in Q4 2025 per OBIO's latest filing, from $2.5 million in the prior quarter.
• Across five years, Long-Term Investments topped out at $160.2 million in Q2 2022 and bottomed at $2.5 million in Q4 2022.
• Historically, Long-Term Investments has averaged $53.0 million across 5 years, with a median of $2.5 million in 2024.
• Annual changes were most pronounced in 2023 — Long-Term Investments tumbled 98.44% — and 2024, when it rose 0.2%.
• Orchestra BioMed Holdings' Long-Term Investments stood at $160.0 million in 2021, then tumbled by 98.44% to $2.5 million in 2022, then changed by 0.0% to $2.5 million in 2023, then changed by 0.0% to $2.5 million in 2024, then gained by 0.2% to $2.5 million in 2025.
• Business Quant data shows OBIO's Long-Term Investments at $2.5 million in Q4 2025, $2.5 million in Q3 2025, and $2.5 million in Q2 2025.